ACHL

ACHL


Assessing Department-specific Antibiotic Susceptibility to Guide Selection and Improve Outcomes - Management of cUTIs

A faculty panel will discuss a case relating to the assessment and treatment of cUTIs. Topics will include emerging technologies for diagnosis, common pathogens, and the selection of therapy for resistant gram-negative infections. The purpose of this activity is to provide members of antimicrobial stewardship programs and clinicians who care for patients with serious infections with the l...
ACHL

Assessing Department-specific Antibiotic Susceptibility to Guide Selection and Improve Outcomes - Selection of Therapy for HAP/VAP

This activity will feature a faculty panel discussing the treatment of a patient with HAP/VAP. Discussions will center around resistant gram-negative pathogens, the selection of therapy, and the role of newer antimicrobial therapies. The purpose of this activity is to provide members of antimicrobial stewardship programs and clinicians who care for patients with serious infections with ...
ACHL

At-risk Populations and Prevention of HPV-related Cancers: From Children to Adults

The purpose of this activity is to educate diverse clinicians on the burden of HPV infections and recent data demonstrating the safety and population benefits of HPV vaccination in the prevention of HPV-related cancers. Armed with this information, clinicians can effectively counsel patients on the importance of vaccination.
ACHL

Clinical Case Challenges: Strategies to Optimize Primary Immunodeficiency Management

Primary care providers, internists, and other general practitioners may be the first to see a patient with PI and require a level of awareness. Yet, a survey issued by the American Academy of Allergy Asthma and Immunology and the Immune Deficiency Foundation found that only 4% of primary care practitioners were aware that guidelines existed for the diagnosis and management of primary immunodefic...
ACHL

Clinical Updates in Chronic Myeloid Leukemia: New Understandings in Disease Diagnosis, Monitoring and Personalized Therapeutic Regimens Utilizing Tyrosine Kinase Inhibitors

Advance your understanding on how to better diagnose, treat, and monitor CML. Expert faculty from MD Anderson recently gave a series of lectures across the country on the latest research and treatment regimen recommendations in CML. Highlighting key takeaways from this meeting series, faculty review the role of ABL tyrosine kinase inhibitor (TKI) agents in advancing treatment and delivering up-t...
ACHL

Evaluating Long-term Atherothrombotic Risks and Combination Antithrombotic Therapy in CAD Patients

Patients who experience a cardiovascular event and/or have peripheral artery disease require long-term antithrombotic prophylaxis to reduce the risk of recurrent cardiac events. Formulating complex regimens for secondary prevention of subsequent cardiovascular events and improved long-term cardiovascular outcomes poses a significant clinical challenge, and patients continue to experience events ...
Indiana University School of Medicine

Evaluating the Risk of Major Adverse Limb Events and Antithrombotic Therapy in PAD Patients

Patients who experience a cardiovascular event and/or have peripheral artery disease require long-term antithrombotic prophylaxis to reduce the risk of recurrent cardiac events. Formulating complex regimens for secondary prevention of subsequent cardiovascular events and improved long-term cardiovascular outcomes poses a significant clinical challenge, and patients continue to experience events ...
Indiana University School of Medicine

Exploring the Future of IBD Care: The Role of JAK Inhibitors

Advance your understanding on new and innovative approaches to care, focusing on the role of JAK Inhibitors in the treatment of IBD. Leading US gastroenterology faculty recently gave a series of lectures across the country on the latest research and treatment regimen recommendations in IBD to enhance optimal health outcomes. Thomas Ullman, MD, Chief of the Division of Gastroenterology at Mon...
ACHL

From Diagnosis to Treatment: The Evolution of SSc-ILD

Explore this 45-minute multi-media eNewsletter that will advance your understanding of systemic sclerosis interstitial lung disease (SSc-ILD) with Dr. Ganesh Raghu, Director of the University of Washington Interstitial Lung Disease/Sarcoid/Pulmonary Fibrosis Program. While there have been significant advances in our understanding of SSc-ILD, there are important unmet needs that still must be...
ACHL

JAK-STAT-GO: Personalized, Targeted Therapy Options for Your IBD Patients

How can clinicians know they have current information for improving patients’ IBD outcomes? Expert faculty from the Icahn School of Medicine at Mount Sinai, University of Chicago Medicine and Biological Sciences, and Montefiore Medical Center/Albert Einstein College of Medicine recently led a symposium at a major gastroenterology meeting exploring the latest in treat-to-target paradigms, the r...
ACHL

New Developments in PAH: Practice Strategies with Competing Novel PAH Guidelines

This interactive infographic format provides up-to-date information on disease classification, risk stratification, and diagnostic and treatment algorithms for PAH. Using a highly visual self-directed platform, Dan Schuller, MD, creates a practical framework to translate CHEST guideline updates for PAH diagnosis and treatment into clinical practice. Learners navigate at their own pace through an...
ACHL

Optimizing Antibiotic Therapy to Treat Gram-negative Pathogens and Improve Outcomes in HAP/VAP

George Karam, MD reviews a HAP/VAP patient case presented along with a faculty panel at MAD-ID 2019. Discussion topics include challenges with P. aeruginosa, ensuring effectiveness of antibiotics while reducing resistance, as well as new and emerging approaches to Gram-negative organisms. The purpose of this activity is to provide clinicians who care for patients with serious infections with...
ACHL

Targeted Nutrition Delivery in Critically Ill Patients: Focus on Protein Needs and Delivery

Filmed in conjunction with APSEN 2019 Nutrition Science and Practice Conference, this activity features an expert panel who discuss nutritional support for critically ill patients including a comparison of guidelines, the importance of tailoring therapy to optimize protein delivery, and the appropriate use of new and emerging high-protein/energy-restricted PN products in hospital settings. T...
ACHL

The Evolving Role of Nutrition Therapy in the Hospitalized Patient: Focus on Lipids and Protein

Despite recognition of underfeeding in hospital settings and its consequences, a substantial number of hospitalized patients can be characterized as malnourished. In this roundtable discussion, Canadian and US-based faculty discuss diagnostic criteria for malnutrition, available and emerging lipid emulsion products and their influence on inflammation and ensuring adequate protein delivery for op...
ACHL

The Right Drugs at the Right Time: The Cost-Savings Case for Tying PAH Formulary Protocols to Best Available Clinical Evidence

Our expert faculty, comprised of a managed care pharmacist and pulmonologist specializing in PAH, review recent guideline recommendations and strategies for selecting appropriate therapy, including initial combination regimens, as well as financial considerations based on managed care pharmacy protocols. Therapeutic selection and management in PAH are intertwined with differential diagnostics...
ACHL

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.